Who should not take GLP-1s GLP-1s in all forms are unsuitable for people who: are pregnant or breastfeeding do not meet the eligibility criteria have a family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2) Medical Perspective Patients with needle phobia, a preference for pill-based routines, or good adherence to oral administration guidelines may be better suited to oral GLP-1 formulations like semaglutide (Rybelsus, Wegovy), which can enhance treatment acceptance and potentially offer strong glycemic or weight control
Versatile Applications: Effective in treating a variety of conditions including tendon injuries, ligament sprains, and ulcers
Consistent complaints about poor communication, unsafe products, or unprofessional behavior are warning signs
Published results are expected later in 2026
The effect on gastric emptying can alter the absorption of other oral medications, so discuss all your medications with your healthcare provider
Foundayo inclusion subject to CMS confirmation